nach oben

Endocrine

Erschienen in:

26.07.2019 | Review

Thyroid hormone therapy in congenital hypothyroidism and pediatric hypothyroidism

verfasst von: Andrew J. Bauer, Ari J. Wassner

Erschienen in: Endocrine | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

The evaluation and management of hypothyroidism in children are similar to adults, but there are important differences based on the dependence on normal thyroid function for neurocognitive and physical development. In the pediatric population, hypothyroidism is frequently categorized as congenital or acquired hypothyroidism, depending on the age of presentation and the underlying etiology. The evaluation and management of children and adolescents with hypothyroidism are determined by the etiology as well as by the age at diagnosis, severity of the hypothyroidism, and the response to thyroid hormone replacement therapy. Children and adolescents require higher weight-based doses for thyroid hormone replacement than do adults, likely due to a shorter half-life of thyroxine (T4) and triiodothyronine (T3) in children, but weight-based dose requirements decrease as the child advances into adulthood. Multiple gaps in knowledge remains regarding how to optimize the treatment of hypothyroidism in pediatric patients, including (but not limited to) the selection of patients with subclinical hypothyroidism for treatment, and the potential benefit of combined LT3/LT4 therapy for patients with persistent symptoms and/or low T3 on LT4 monotherapy. The life-long impact on growth and development, and potentially on long-term cardiovascular and psychosocial health, are significant and highlight the importance of future prospective studies in pediatric patients to explore these areas of uncertainty.

L.P. Fernandez, A. Lopez-Marquez, P. Santisteban, Thyroid transcription factors in development, differentiation and disease. Nat. Rev. Endocrinol. 11(1), 29–42 (2015). https://doi.org/10.1038/nrendo.2014.186 CrossRefPubMed

P. Hanley, K. Lord, A.J. Bauer, Thyroid disorders in children and adolescents: a review. JAMA Pedia. 170(10), 1008–1019 (2016). https://doi.org/10.1001/jamapediatrics.2016.0486 CrossRef

A.A. Kurmann, M. Serra, F. Hawkins, S.A. Rankin, M. Mori, I. Astapova, S. Ullas, S. Lin, M. Bilodeau, J. Rossant, J.C. Jean, L. Ikonomou, R.R. Deterding, J.M. Shannon, A.M. Zorn, A.N. Hollenberg, D.N. Kotton, Regeneration of thyroid function by transplantation of differentiated pluripotent stem cells. Cell Stem Cell 17(5), 527–542 (2015). https://doi.org/10.1016/j.stem.2015.09.004 CrossRefPubMedPubMedCentral

D.A. Fisher, W.D. Odell, Acute release of thyrotropin in the newborn. J. Clin. Investig. 48(9), 1670–1677 (1969). https://doi.org/10.1172/JCI106132 CrossRefPubMed

G. Gunapalasingham, C. Frithioff-Bojsoe, M.A.V. Lund, P.L. Hedley, C.E. Fonvig, M. Dahl, O. Pedersen, M. Christiansen, T. Hansen, U. Lausten-Thomsen, J.C. Holm, Reference values for fasting serum concentrations of thyroid-stimulating hormone and thyroid hormones in healthy Danish/North-European white children and adolescents. Scand. J. Clin. Lab. Investig. 79(1-2), 129–135 (2019). https://doi.org/10.1080/00365513.2019.1581945 CrossRef

A.J. Lem, Y.B. de Rijke, H. van Toor, M.A. de Ridder, T.J. Visser, A.C. Hokken-Koelega, Serum thyroid hormone levels in healthy children from birth to adulthood and in short children born small for gestational age. J. Clin. Endocrinol. Metab. 97(9), 3170–3178 (2012). https://doi.org/10.1210/jc.2012-1759 CrossRefPubMed

J. Simpson, F.L. Williams, C. Delahunty, H. van Toor, S.Y. Wu, S.A. Ogston, T.J. Visser, R. Hume, Scottish Preterm Thyroid, G.: Serum thyroid hormones in preterm infants and relationships to indices of severity of intercurrent illness. J. Clin. Endocrinol. Metab. 90(3), 1271–1279 (2005). https://doi.org/10.1210/jc.2004-2091 CrossRefPubMed

F.L. Williams, J. Simpson, C. Delahunty, S.A. Ogston, J.J. Bongers-Schokking, N. Murphy, H. van Toor, S.Y. Wu, T.J. Visser, R. Hume,Collaboration from the Scottish Preterm Thyroid, G, Developmental trends in cord and postpartum serum thyroid hormones in preterm infants. J. Clin. Endocrinol. Metab. 89(11), 5314–5320 (2004). https://doi.org/10.1210/jc.2004-0869 CrossRefPubMed

A.M. Dumitrescu, S. Refetoff, S., in Impaired Sensitivity to Thyroid Hormone: Defects of Transport, Metabolism and Action. ed. by K.R. Feingold, B. Anawalt, A. Boyce, G. Chrousos, K. Dungan, A. Grossman, J.M. Hershman, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, R. McLachlan, J.E. Morley, M. New, L. Perreault, J. Purnell, R. Rebar, F. Singer, D.L. Trence, A. Vinik, D.P. Wilson (Endotext, South Dartmouth, MA, 2000)

10.

S. Groeneweg, W.E. Visser, T.J. Visser, Disorder of thyroid hormone transport into the tissues. Best practice & research. Clin. Endocrinol. Metab. 31(2), 241–253 (2017). https://doi.org/10.1016/j.beem.2017.05.001 CrossRef

11.

I. Onsesveren, M. Barjaktarovic, L. Chaker, Y.B. de Rijke, V.W.V. Jaddoe, H.M. van Santen, T.J. Visser, R.P. Peeters, T.I.M. Korevaar, Childhood thyroid function reference ranges and determinants: a literature overview and a prospective cohort study. Thyroid. 27(11), 1360–1369 (2017). https://doi.org/10.1089/thy.2017.0262 CrossRefPubMed

12.

M. Salerno, D. Capalbo, M. Cerbone, F. De Luca, Subclinical hypothyroidism in childhood—current knowledge and open issues. Nat. Rev. Endocrinol. 12(12), 734–746 (2016). https://doi.org/10.1038/nrendo.2016.100 CrossRefPubMed

13.

J.V. Hennessey, The emergence of levothyroxine as a treatment for hypothyroidism. Endocrine 55(1), 6–18 (2017). https://doi.org/10.1007/s12020-016-1199-8 CrossRefPubMed

14.

J.V. Hennessey, Historical and current perspective in the use of thyroid extracts for the treatment of hypothyroidism. Endocr. Pract. 21(10), 1161–1170 (2015). https://doi.org/10.4158/EP14477.RA CrossRefPubMed

15.

M.J. Kilberg, I.R. Rasooly, S.H. LaFranchi, A.J. Bauer, C.P. Hawkes, Newborn Screening in the US May Miss Mild Persistent Hypothyroidism. J. Pediatr. 192, 204–208 (2018). https://doi.org/10.1016/j.jpeds.2017.09.003 CrossRefPubMedPubMedCentral

16.

R. Abu-Khudir, S. Larrivee-Vanier, J.D. Wasserman, J. Deladoey, Disorders of thyroid morphogenesis. Best practice & research. Clin. Endocrinol. Metab. 31(2), 143–159 (2017). https://doi.org/10.1016/j.beem.2017.04.008 CrossRef

17.

M.J. Kwak, Clinical genetics of defects in thyroid hormone synthesis. Ann. Pediatr. Endocrinol. Metab. 23(4), 169–175 (2018). https://doi.org/10.6065/apem.2018.23.4.169 CrossRefPubMedPubMedCentral

18.

C. Peters, A.S.P. van Trotsenburg, N. Schoenmakers, O.F. DIAGNOSIS, Endocrine disease: congenital hypothyroidism: update and perspectives. Eur. J. Endocrinol. 179(6), R297–R317 (2018). https://doi.org/10.1530/EJE-18-0383 CrossRefPubMed

19.

D.A. van Tijn, J.J. de Vijlder, B. Verbeeten Jr., P.H. Verkerk, T. Vulsma, Neonatal detection of congenital hypothyroidism of central origin. J. Clin. Endocrinol. Metab. 90(6), 3350–3359 (2005). https://doi.org/10.1210/jc.2004-2444 CrossRefPubMed

20.

M.B. Belfort, E.N. Pearce, L.E. Braverman, X. He, R.S. Brown, Low iodine content in the diets of hospitalized preterm infants. J. Clin. Endocrinol. Metab. 97(4), E632–E636 (2012). https://doi.org/10.1210/jc.2011-3369 CrossRefPubMedPubMedCentral

21.

J.E. Pinsker, K. McBayne, M. Edwards, K. Jensen, D.F. Crudo, A.J. Bauer, Transient hypothyroidism in premature infants after short-term topical iodine exposure: an avoidable risk? Pediatr. Neonatol. 54(2), 128–131 (2013). https://doi.org/10.1016/j.pedneo.2012.10.005 CrossRefPubMed

22.

A. Creo, H. Anderson, P. B. Cannon, A. Lteif, S. Kumar, P. Tebben, A.M. Iqbal, A. Ramakrishna, S. Pittock, Patterns of amiodarone-induced thyroid dysfunction in infants and children. Heart Rhythm (2019). https://doi.org/10.1016/j.hrthm.2019.03.015

23.

M.L. Barr, H.K. Chiu, N. Li, M.W. Yeh, C.M. Rhee, J. Casillas, P.J. Iskander, A.M. Leung, Thyroid dysfunction in children exposed to iodinated contrast media. J. Clin. Endocrinol. Metab. 101(6), 2366–2370 (2016). https://doi.org/10.1210/jc.2016-1330 CrossRefPubMedPubMedCentral

24.

S.S. Jick, M. Hedderson, F. Xu, Y. Cheng, P. Palkowitsch, A. Michel, Iodinated contrast agents and risk of hypothyroidism in young children in the United States. Investig Radio. 54(5), 296–301 (2019). https://doi.org/10.1097/RLI.0000000000000541 CrossRef

25.

J. Farebrother, M.B. Zimmermann, M. Andersson, Excess iodine intake: sources, assessment, and effects on thyroid function. Ann. N. Y Acad. Sci. 1446(1), 44–65 (2019). https://doi.org/10.1111/nyas.14041 CrossRefPubMed

26.

R.S. Brown, C.A. Alter, A. Sadeghi-Nejad, Severe unsuspected maternal hypothyroidism discovered after the diagnosis of thyrotropin receptor-blocking antibody-induced congenital hypothyroidism in the neonate: failure to recognize and implications to the fetus. Horm. Res. Paediatr. 83(2), 132–135 (2015). https://doi.org/10.1159/000368671 CrossRefPubMed

27.

B.R. Haugen, Drugs that suppress TSH or cause central hypothyroidism. Best practice & research. Clin. Endocrinol. Metab. 23(6), 793–800 (2009). https://doi.org/10.1016/j.beem.2009.08.003 CrossRef

28.

O. Koulouri, C. Moran, D. Halsall, K. Chatterjee, M. Gurnell, Pitfalls in the measurement and interpretation of thyroid function tests. Best practice & research. Clin. Endocrinol. Metab. 27(6), 745–762 (2013). https://doi.org/10.1016/j.beem.2013.10.003 CrossRef

29.

J. Leger, A. Olivieri, M. Donaldson, T. Torresani, H. Krude, G. van Vliet, M. Polak, G. Butler, European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. J. Clin. Endocrinol. Metab. 99(2), 363–384 (2014). https://doi.org/10.1210/jc.2013-1891 CrossRefPubMedPubMedCentral

30.

D.A. Fisher, W.D. Odell, C.J. Hobel, R. Garza, Thyroid function in the term fetus. Pediatrics 44(4), 526–535 (1969)PubMed

31.

J. Leger, A. Olivieri, M. Donaldson, T. Torresani, H. Krude, G. van Vliet, M. Polak, G. Butler, European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. Horm. Res. Paediatr. 81(2), 80–103 (2014). https://doi.org/10.1159/000358198 CrossRefPubMed

32.

N. McGrath, C.P. Hawkes, P. Mayne, N.P. Murphy, Permanent decompensated congenital hypothyroidism in newborns with whole-blood thyroid-stimulating hormone concentrations between 8 and 10 mU/L: the case for lowering the threshold. Horm. Res. Paediatr. 89(4), 265–270 (2018). https://doi.org/10.1159/000488288 CrossRefPubMed

33.

S. Rabbiosi, M.C. Vigone, F. Cortinovis, I. Zamproni, L. Fugazzola, L. Persani, C. Corbetta, G. Chiumello, G. Weber, Congenital hypothyroidism with eutopic thyroid gland: analysis of clinical and biochemical features at diagnosis and after re-evaluation. J. Clin. Endocrinol. Metab. 98(4), 1395–1402 (2013). https://doi.org/10.1210/jc.2012-3174 CrossRefPubMed

34.

S.D. Grosse, G. Van Vliet, Prevention of intellectual disability through screening for congenital hypothyroidism: how much and at what level? Arch. Dis. Child. 96(4), 374–379 (2011). https://doi.org/10.1136/adc.2010.190280 CrossRefPubMed

35.

S.J. Lain, J.P. Bentley, V. Wiley, C.L. Roberts, M. Jack, B. Wilcken, N. Nassar, Association between borderline neonatal thyroid-stimulating hormone concentrations and educational and developmental outcomes: a population-based record-linkage study. Lancet Diabetes Endocrinol. 4(9), 756–765 (2016). https://doi.org/10.1016/S2213-8587(16)30122-X CrossRefPubMed

36.

C. Trumpff, J. De Schepper, J. Vanderfaeillie, N. Vercruysse, H. Van Oyen, R. Moreno-Reyes, J. Tafforeau, S. Vandevijvere, Neonatal thyroid-stimulating hormone concentration and psychomotor development at preschool age. Arch. Dis. Child. 101(12), 1100–1106 (2016). https://doi.org/10.1136/archdischild-2015-310006 CrossRefPubMedPubMedCentral

37.

S. Lain, C. Trumpff, S.D. Grosse, A. Olivieri, G. Van Vliet, Are lower TSH cutoffs in neonatal screening for congenital hypothyroidism warranted? Eur. J. Endocrinol. 177(5), D1–D12 (2017). https://doi.org/10.1530/EJE-17-0107 CrossRefPubMedPubMedCentral

38.

J.J. Bongers-Schokking, W.C. Resing, Y.B. de Rijke, M.A. de Ridder, S.M. de Muinck Keizer-Schrama, Cognitive development in congenital hypothyroidism: is overtreatment a greater threat than undertreatment? J. Clin. Endocrinol. Metab. 98(11), 4499–4506 (2013). https://doi.org/10.1210/jc.2013-2175 CrossRefPubMed

39.

J.J. Bongers-Schokking, W.C.M. Resing, W. Oostdijk, Y.B. de Rijke, S.de Muinck Keizer-Schrama, Relation between early over- and undertreatment and behavioural problems in preadolescent children with congenital hypothyroidism. Horm. Res. Paediatr. 90(4), 247–256 (2018). https://doi.org/10.1159/000494056 CrossRefPubMedPubMedCentral

40.

P.E. Aleksander, M. Bruckner-Spieler, A.M. Stoehr, E. Lankes, P. Kuhnen, D. Schnabel, A. Ernert, W. Stablein, M.E. Craig, O. Blankenstein, A. Gruters, H. Krude, Mean high-dose l-thyroxine treatment is efficient and safe to achieve a normal iq in young adult patients with congenital hypothyroidism. J. Clin. Endocrinol. Metab. 103(4), 1459–1469 (2018). https://doi.org/10.1210/jc.2017-01937 CrossRefPubMed

41.

D.A. Fisher, E.J. Schoen, S. La Franchi, S.H. Mandel, J.C. Nelson, E.I. Carlton, J.H. Goshi, The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism. J. Clin. Endocrinol. Metab. 85(8), 2722–2727 (2000). https://doi.org/10.1210/jcem.85.8.6718 CrossRefPubMed

42.

L. Paone, A.F. Fleisch, H.A. Feldman, R.S. Brown, A.J. Wassner, Liothyronine improves biochemical control of congenital hypothyroidism in patients with central resistance to thyroid hormone. J. Pediatr. 175, 167–172 e161 (2016). https://doi.org/10.1016/j.jpeds.2016.04.022 CrossRefPubMedPubMedCentral

43.

J.M. Carswell, J.H. Gordon, E. Popovsky, A. Hale, R.S. Brown, Generic and brand-name l-thyroxine are not bioequivalent for children with severe congenital hypothyroidism. J. Clin. Endocrinol. Metab. 98(2), 610–617 (2013). https://doi.org/10.1210/jc.2012-3125 CrossRefPubMed

44.

A. Bernareggi, E. Grata, M.T. Pinorini, A. Conti, Oral liquid formulation of levothyroxine is stable in breakfast beverages and may improve thyroid patient compliance. Pharmaceutics 5(4), 621–633 (2013). https://doi.org/10.3390/pharmaceutics5040621 CrossRefPubMedPubMedCentral

45.

A. Cassio, S. Monti, A. Rizzello, I. Bettocchi, F. Baronio, G. D’Addabbo, M.O. Bal, A. Balsamo, Comparison between liquid and tablet formulations of levothyroxine in the initial treatment of congenital hypothyroidism. J. Pediatr. 162(6), 1264–1269 (2013). https://doi.org/10.1016/j.jpeds.2012.11.070. 1269 e1261-1262CrossRefPubMed

46.

E. Peroni, M.C. Vigone, S. Mora, L.A. Bassi, C. Pozzi, A. Passoni, G. Weber, Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine. Horm. Res. Paediatr. 81(1), 50–54 (2014). https://doi.org/10.1159/000356047 CrossRefPubMed

47.

A. Corbacioglu Esmer, A. Gul, H. Dagdeviren, I. Turan Bakirci, O. Sahin, Intrauterine diagnosis and treatment of fetal goitrous hypothyroidism. J. Obstet. Gynaecol. Res 39(3), 720–723 (2013). https://doi.org/10.1111/j.1447-0756.2012.02003.x CrossRefPubMed

48.

K.M. Davidson, D.S. Richards, D.A. Schatz, D.A. Fisher, Successful in utero treatment of fetal goiter and hypothyroidism. N. Engl. J. Med. 324(8), 543–546 (1991). https://doi.org/10.1056/NEJM199102213240807 CrossRefPubMed

49.

M. Polak, D. Luton, Fetal thyroidology. Best practice & research. Clin. Endocrinol. Metab. 28(2), 161–173 (2014). https://doi.org/10.1016/j.beem.2013.04.013 CrossRef

50.

P. Vasudevan, C. Powell, A.K. Nicholas, I. Scudamore, J. Greening, S.M. Park, N. Schoenmakers, Intrauterine death following intraamniotic triiodothyronine and thyroxine therapy for fetal goitrous hypothyroidism associated with polyhydramnios and caused by a thyroglobulin mutation. Endocrinol. Diabetes Metab. Case Rep. 2017 (2017). https://doi.org/10.1530/EDM-17-0040

51.

A. Hauri-Hohl, N. Dusoczky, A. Dimitropoulos, R.H. Leuchter, L. Molinari, J. Caflisch, O.G. Jenni, B. Latal, Impaired neuromotor outcome in school-age children with congenital hypothyroidism receiving early high-dose substitution treatment. Pediatr. Res 70(6), 614–618 (2011). https://doi.org/10.1203/PDR.0b013e3182321128 CrossRefPubMed

52.

J. Leger, Congenital hypothyroidism: a clinical update of long-term outcome in young adults. Eur. J. Endocrinol. 172(2), R67–R77 (2015). https://doi.org/10.1530/EJE-14-0777 CrossRefPubMed

53.

L. Lichtenberger-Geslin, S. Dos Santos, Y. Hassani, E. Ecosse, T.Van Den Abbeele, J.Leger, Factors associated with hearing impairment in patients with congenital hypothyroidism treated since the neonatal period: a national population-based study. J. Clin. Endocrinol. Metab. 98(9), 3644–3652 (2013). https://doi.org/10.1210/jc.2013-1645 CrossRefPubMed

54.

C.J. Eastman, M.B. Zimmermann, in The Iodine Deficiency Disorders. ed. by K.R. Feingold, B. Anawalt, A. Boyce, G. Chrousos, K. Dungan, A. Grossman, J.M. Hershman, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, R. McLachlan, J. E. Morley, M. New, L. Perreault, J. Purnell, R. Rebar, F. Singer, D.L. Trence, A. Vinik, D.P. Wilson (Endotext, South Dartmouth, MA, 2000)

55.

M. Wasniewska, A. Corrias, M. Salerno, A. Mussa, D. Capalbo, M.F. Messina, T. Aversa, S. Bombaci, F. De Luca, M. Valenzise, Thyroid function patterns at Hashimoto’s thyroiditis presentation in childhood and adolescence are mainly conditioned by patients’ age. Horm. Res. Paediatr. 78(4), 232–236 (2012). https://doi.org/10.1159/000343815 CrossRefPubMed

56.

P.A. Gibson, R.W. Newton, K. Selby, D.A. Price, K. Leyland, G.M. Addison, Longitudinal study of thyroid function in Down’s syndrome in the first two decades. Arch. Dis. Child. 90(6), 574–578 (2005). https://doi.org/10.1136/adc.2004.049536 CrossRefPubMedPubMedCentral

57.

S. McGowan, J. Jones, A. Brown, L. Reynolds, K. Leyland, P. Charleton, M. Rahim, M. Mansor, S. Ritha, M. Donaldson, Capillary TSH screening programme for Down’s syndrome in Scotland, 1997–2009. Arch. Dis. Child. 96(12), 1113–1117 (2011). https://doi.org/10.1136/archdischild-2011-300124 CrossRefPubMed

58.

J.L. Frias, M.L. Davenport, Health supervision for children with Turner syndrome. Pediatrics 111(3), 692–702 (2003)CrossRef

59.

A. Gawlik, T. Gawlik, A. Januszek-Trzciakowska, H. Patel, E. Malecka-Tendera, Incidence and dynamics of thyroid dysfunction and thyroid autoimmunity in girls with Turner’s syndrome: a long-term follow-up study. Horm. Res. Paediatr. 76(5), 314–320 (2011). https://doi.org/10.1159/000331050 CrossRefPubMed

60.

E. Piatkowska, M. Szalecki, Autoimmune thyroiditis in children and adolescents with type 1 diabetes. Pediatr. Endocrinol., diabetes, Metab. 17(4), 173–177 (2011)

61.

S. Severinski, S. Banac, N.S. Severinski, V. Ahel, K. Cvijovic, Epidemiology and clinical characteristics of thyroid dysfunction in children and adolescents with type 1 diabetes. Coll. Antropol. 33(1), 273–279 (2009)PubMed

62.

A. Rojas-Villarraga, J. Amaya-Amaya, A. Rodriguez-Rodriguez, R.D. Mantilla, J.M. Anaya, Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmune Dis. 2012, 254319 (2012). https://doi.org/10.1155/2012/254319 CrossRefPubMedPubMedCentral

63.

W. Chemaitilly, C.A. Sklar, Endocrine complications in long-term survivors of childhood cancers. Endocr.-Relat. Cancer 17(3), R141–R159 (2010). https://doi.org/10.1677/ERC-10-0002 CrossRefPubMed

64.

M. Demirkaya, B. Sevinir, H. Saglam, L. Ozkan, O. Akaci, Thyroid functions in long-term survivors of pediatric Hodgkin’s lymphoma treated with chemotherapy and radiotherapy. J. Clin. Res. Pediatr. Endocrinol. 3(2), 89–94 (2011). https://doi.org/10.4274/jcrpe.v3i2.18 CrossRefPubMedPubMedCentral

65.

M. Weber Pasa, R. Selbach Scheffel, A. Borsatto Zanella, A.L. Maia, J.M. Dora, Consumptive hypothyroidism: case report of hepatic hemangioendotheliomas successfully treated with vincristine and systematic review of the syndrome. Eur. Thyroid J. 6(6), 321–327 (2017). https://doi.org/10.1159/000481253 CrossRefPubMedPubMedCentral

66.

S.A. Huang, H.M. Tu, J.W. Harney, M. Venihaki, A.J. Butte, H.P. Kozakewich, S.J. Fishman, P.R. Larsen, Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N. Engl. J. Med. 343(3), 185–189 (2000). https://doi.org/10.1056/NEJM200007203430305 CrossRefPubMed

67.

N. Jassam, T.J. Visser, T. Brisco, D. Bathia, P. McClean, J.H. Barth, Consumptive hypothyroidism: a case report and review of the literature. Ann. Clin. Biochem. 48(Pt 2), 186–189 (2011). https://doi.org/10.1258/acb.2010.010170 CrossRefPubMed

68.

M.C. Vigone, F. Cortinovis, S. Rabbiosi, M. Di Frenna, A. Passoni, L. Persani, G. Chiumello, C. Gelmetti, G. Weber, Difficult treatment of consumptive hypothyroidism in a child with massive parotid hemangioma. J. Pediatr. Endocrinol. Metab. 25(1-2), 153–155 (2012)CrossRef

69.

J. Jonklaas, A.C. Bianco, A.J. Bauer, K.D. Burman, A.R. Cappola, F.S. Celi, D.S. Cooper, B.W. Kim, R.P. Peeters, M.S. Rosenthal, A.M. Sawka, American Thyroid Association Task Force on Thyroid Hormone, R.: guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 24(12), 1670–1751 (2014). https://doi.org/10.1089/thy.2014.0028 CrossRefPubMedPubMedCentral

70.

S.M. Cabrera, L.A. DiMeglio, E.A. Eugster, Incidence and characteristics of pseudoprecocious puberty because of severe primary hypothyroidism. J. Pediatr. 162(3), 637–639 (2013). https://doi.org/10.1016/j.jpeds.2012.10.043 CrossRefPubMed

71.

N.S. Larson, J.E. Pinsker, Primary hypothyroidism with growth failure and pituitary pseudotumor in a 13-year-old female: a case report. J. Med Case Rep. 7, 149 (2013). https://doi.org/10.1186/1752-1947-7-149 CrossRefPubMedPubMedCentral

72.

T.D. Nebesio, M.D. Wise, S.M. Perkins, E.A. Eugster, Does clinical management impact height potential in children with severe acquired hypothyroidism? J. Pediatr. Endocrinol. Metab. 24(11-12), 893–896 (2011)CrossRef

73.

J.B. Quintos, M. Salas, Use of growth hormone and gonadotropin releasing hormone agonist in addition to L-thyroxine to attain normal adult height in two patients with severe Hashimoto’s thyroiditis. J. Pediatr. Endocrinol. Metab. 18(5), 515–521 (2005)CrossRef

74.

K.L. Durbin, T. Diaz-Montes, M.B. Loveless, Van wyk and grumbach syndrome: an unusual case and review of the literature. J. Pedia. Adolesc. Gynecol. 24(4), e93–e96 (2011). https://doi.org/10.1016/j.jpag.2010.08.003 CrossRef

75.

K.S. Eom, C. See-Sung, J.D. Kim, J.M. Kim, T.Y. Kim, Primary hypothyroidism mimicking a pituitary macroadenoma: regression after thyroid hormone replacement therapy. Pediatr. Radiol. 39(2), 164–167 (2009). https://doi.org/10.1007/s00247-008-1012-9 CrossRefPubMed

76.

A.S. Joshi, P.D. Woolf, Pituitary hyperplasia secondary to primary hypothyroidism: a case report and review of the literature. Pituitary 8(2), 99–103 (2005). https://doi.org/10.1007/s11102-005-3281-8 CrossRefPubMed

77.

L. Gaspari, F. Paris, N. Leboucq, A. Bonafe, C. Sultan, Reversible growth failure and complete GH deficiency in a 4-year-old girl with very early Hashimoto’s thyroiditis and subsequent hyperplasia of pituitary thyrotroph cells. Eur. J. Pediatr. 175(8), 1119–1122 (2016). https://doi.org/10.1007/s00431-016-2698-6 CrossRefPubMed

78.

T. Aversa, A. Corrias, M. Salerno, D. Tessaris, R. Di Mase, M. Valenzise, D. Corica, F. De Luca, M. Wasniewska, Five-year prospective evaluation of thyroid function test evolution in children with hashimoto’s thyroiditis presenting with either euthyroidism or subclinical hypothyroidism. Thyroid. Assoc. 26(10), 1450–1456 (2016). https://doi.org/10.1089/thy.2016.0080 CrossRef

79.

G. Crisafulli, R. Gallizzi, T. Aversa, G. Salzano, M. Valenzise, M. Wasniewska, F. De Luca, G. Zirilli, Thyroid function test evolution in children with Hashimoto’s thyroiditis is closely conditioned by the biochemical picture at diagnosis. Ital. J. Pediatr. 44(1), 22 (2018). https://doi.org/10.1186/s13052-018-0461-5 CrossRefPubMedPubMedCentral

80.

R.K. Marwaha, N. Tandon, R. Kanwar, M.A. Ganie, V. Bhattacharya, D.H. Reddy, S. Gopalakrishnan, R. Aggarwal, K. Grewal, S.K. Ganguly, K. Mani, Evaluation of the role of ultrasonography in diagnosis of autoimmune thyroiditis in goitrous children. Indian Pediatr. 45(4), 279–284 (2008)PubMed

81.

M.S. Durmaz, N. Akyurek, T. Kara, F. Ates, B. Ozbakir, F. G. Durmaz, S. S. Karaagac, M. Ozturk, Quantitative assessment of thyroid gland vascularization with vascularization index using color superb microvascular imaging in pediatric patients with hashimoto thyroiditis. Ultrasound Q (2019). https://doi.org/10.1097/RUQ.0000000000000430

82.

S.H. Jeong, H.S. Hong, J.Y. Lee, The association between thyroid echogenicity and thyroid function in pediatric and adolescent Hashimoto’s thyroiditis. Med. (Baltim.) 98(14), e15055 (2019). https://doi.org/10.1097/MD.0000000000015055 CrossRef

83.

J. Szczyrski, W. Kosiak, M. Korpal-Szczyrska, M. Mysliwiec, Ultrasound image of the thyroid gland in obese children. J. Ultrason 15(63), 423–428 (2015). https://doi.org/10.15557/JoU.2015.0039 CrossRefPubMedPubMedCentral

84.

A. Lollert, C. Gies, K. Laudemann, J. Faber, D. Jacob-Heutmann, J. Konig, C. Duber, G. Staatz, Ultrasound evaluation of thyroid gland pathologies after radiation therapy and chemotherapy to treat malignancy during childhood. Int J. Radiat. Oncol. Biol. Phys. 94(1), 139–146 (2016). https://doi.org/10.1016/j.ijrobp.2015.09.016 CrossRefPubMed

85.

J.L. Williams, D.L. Paul, G. Bisset 3rd, Thyroid disease in children: part 1: state-of-the-art imaging in pediatric hypothyroidism. Pedia. Radio. 43(10), 1244–1253 (2013). https://doi.org/10.1007/s00247-013-2735-9 CrossRef

86.

J. Jonklaas, A.C. Bianco, A.J. Bauer, K.D. Burman, A.R. Cappola, F.S. Celi, D.S. Cooper, B.W. Kim, R.P. Peeters, M.S. Rosenthal, A.M. Sawka, Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 24(12), 1670–1751 (2014). https://doi.org/10.1089/thy.2014.0028 CrossRefPubMedPubMedCentral

87.

J.F. Rovet, D. Daneman, J.D. Bailey, Psychologic and psychoeducational consequences of thyroxine therapy for juvenile acquired hypothyroidism. J. Pediatr. 122(4), 543–549 (1993). https://doi.org/10.1016/s0022-3476(05)83533-4 CrossRefPubMed

88.

C. Van Dop, F.A. Conte, T.K. Koch, S.J. Clark, S.L. Wilson-Davis, M.M. Grumbach, Pseudotumor cerebri associated with initiation of levothyroxine therapy for juvenile hypothyroidism. N. Engl. J. Med. 308(18), 1076–1080 (1983). https://doi.org/10.1056/NEJM198305053081807 CrossRefPubMed

89.

H. Gharib, R.M. Tuttle, H.J. Baskin, L.H. Fish, P.A. Singer, M.T. McDermott, Consensus statement #1: subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. Thyroid. 15(1), 24–28 (2005). https://doi.org/10.1089/thy.2005.15.24. response 32-23CrossRefPubMed

90.

P.B. Kaplowitz, Subclinical hypothyroidism in children: normal variation or sign of a failing thyroid gland? Int. J. Pediatr. Endocrinol. 2010, 281453 (2010). https://doi.org/10.1155/2010/281453 CrossRefPubMedPubMedCentral

91.

M.J. O’Grady, D. Cody, Subclinical hypothyroidism in childhood. Arch. Dis. Child. 96(3), 280–284 (2011). https://doi.org/10.1136/adc.2009.181800 CrossRefPubMed

92.

M. Cerbone, C. Bravaccio, D. Capalbo, M. Polizzi, M. Wasniewska, D. Cioffi, N. Improda, M. Valenzise, D. Bruzzese, F. De Luca, M. Salerno, Linear growth and intellectual outcome in children with long-term idiopathic subclinical hypothyroidism. Eur. J. Endocrinol. 164(4), 591–597 (2011). https://doi.org/10.1530/EJE-10-0979 CrossRefPubMed

93.

L.H. Duntas, L. Wartofsky, Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? Thyroid. 17(11), 1075–1084 (2007). https://doi.org/10.1089/thy.2007.0116 CrossRefPubMed

94.

O. Akin, Morning vs. bedtime levothyroxine administration: what is the ideal choice for children? J. Pediatr. Endocrinol. Metab. 31(11), 1249–1255 (2018). https://doi.org/10.1515/jpem-2018-0168 CrossRefPubMed

95.

K.D. Coyne, K.A. Trimble, A. Lloyd, L. Petrando, J. Pentz, K. Van Namen, A. Fawcett, C.M. Laing, Interventions to promote oral medication adherence in the pediatric chronic illness population: a systematic review from the Children’s Oncology Group. J. Pedia. Oncol. Nurs. 36(3), 219–235 (2019). https://doi.org/10.1177/1043454219835451 CrossRef

96.

P. Colucci, C.S. Yue, M. Ducharme, S. Benvenga, A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism. Eur. Endocrinol. 9(1), 40–47 (2013). https://doi.org/10.17925/EE.2013.09.01.40 CrossRefPubMedPubMedCentral

97.

R. Nanan, J.R. Wall, Remission of Hashimoto’s thyroiditis in a twelve-year-old girl with thyroid changes documented by ultrasonography. Thyroid. 20(10), 1187–1190 (2010). https://doi.org/10.1089/thy.2010.0102 CrossRefPubMed

98.

G.J. Kahaly, D. Schuppan, Celiac disease and endocrine autoimmunity. Dig. Dis. 33(2), 155–161 (2015). https://doi.org/10.1159/000369535 CrossRefPubMed

99.

M.I. Liontiris, E.E. Mazokopakis, A concise review of Hashimoto thyroiditis (HT) and the importance of iodine, selenium, vitamin D and gluten on the autoimmunity and dietary management of HT patients.Points that need more investigation. Hell. J. Nucl. Med. 20(1), 51–56 (2017). https://doi.org/10.1967/s002449910507 CrossRefPubMed

100.

M.P. Rayman, Multiple nutritional factors and thyroid disease, with particular reference to autoimmune thyroid disease. Proc. Nutr. Soc. 78(1), 34–44 (2019). https://doi.org/10.1017/S0029665118001192 CrossRefPubMed

Titel: Thyroid hormone therapy in congenital hypothyroidism and pediatric hypothyroidism
verfasst von: Andrew J. Bauer
Ari J. Wassner
Publikationsdatum: 26.07.2019
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 1/2019
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-019-02024-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Thyroid hormone therapy in congenital hypothyroidism and pediatric hypothyroidism

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Thyroid hormone metabolites and analogues

Novel thyroid hormones

Novel thyroxine formulations: a further step toward precision medicine

Thyroid hormone therapy for subclinical hypothyroidism

Thyroid hormone misuse and abuse

Diagnosis and treatment of hypothyroidism in the elderly

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin